Is there a relationship between asthma severity and abnormalities on chest X-ray?: a pilot study X E Eddy and AM Kelly Objectives: To determine the rate of chest X-ray (CXR) ordering for patients with acute asthma in the emergency department (ED) and the rate of relevant abnormalities on CXR for each asthma severity classification. Methods: Retrospective explicit chart review involving adult ED patients with asthma presenting between 1 July and 31 December 2001. Data collected included severity classification according to the National Asthma Guidelines (NAG) [Australia], demographic information, temperature, white cell count, CXR ordering and findings on CXR. The main outcomes were the rate of CXR ordering and the rate of relevant abnormality on CXR by severity category. Results: Altogether, 158 presentations by 140 patients were analysed. The overall rate of CXR ordering was 68% [mild 54%, moderate 66%, severe 84%]. The overall rate of abnormalities was 8% [mild 0%, moderate 9%, severe 14%]. Ninety-one percent of patients admitted to hospital had CXR of which 13% [8/60] revealed significant abnormalities.
Introduction
There is a variety of opinions about whether chest X-rays (CXR) should be a routine part of the assessment of adult patients presenting to emergency departments (ED) with acute asthma. The National Asthma Guidelines (NAG) [Australia] 1 divide acute asthma episodes into three severity categories according to defined criteria. For mild asthma they state that a CXR is not necessary unless focal signs are present. For moderate asthma, they suggest that a CXR is not necessary unless focal signs are present or there is failure to improve with treatment. For severe episodes, they state that a CXR is necessary if there is no response to initial therapy or there is suspicion of pneumothorax.
Previous studies of ED asthma patients have found that the rate of abnormalities on CXR is very low and have recommended that they be reserved for patients who have focal chest examination findings, require admission or fail to respond to treatment. 2, 3 There is however no Australian data on the rate of CXR use or the rate of CXR abnormality.
The primary aims of this study were to determine the proportion of patients with acute asthma for whom a CXR was ordered, analysed by severity category, and the proportion that showed significant abnormalities.
Methods
This study was an explicit retrospective review of medical records conducted at Western Hospital in Melbourne that had an annual ED census of approximately 33,000 adult patients. Patients were eligible for inclusion if they were adult (aged 16 years or above) with an ED discharge diagnosis of 'asthma' presenting between July and December 2001. Patients were identified from the ED computer database (HASS™) and data were collected on an explicit data collection form.
Data were collected by a single researcher (EE) from the attending doctors' notes, nursing observation charts, and radiology and pathology reports. This included demographic information, clinical assessment to determine asthma severity according to NAG, whether a CXR was performed and CXR findings. The radiology report was considered the 'gold standard' with respect to the presence or absence of relevant abnormalities on CXR.
Relevant CXR abnormality was defined as evidence of consolidation, widespread atelectasis, pneumothorax, pneumomediastinum or neoplasm. The following findings were not considered to be of clinical significance: hyperinflation, bronchial wall thickening or small localised areas of atelectasis. Chronic findings (e.g. abscess, neoplasm) were only counted as positive once in the same patient. A white cell count (WCC) greater than 12 x 10 9 /L was classified as significantly elevated as was a temperature above 38°C.
Interrater reliability for severity classification was m e a s u re d u s i n g a n i n d e p e n d e n t re s e a rc h e r, experienced in reviewing medical files, who analysed a 10% sample of randomly selected records. A Kappa analysis yielding a score of 0.55 would indicate that there was moderate agreement between the two researchers.
Data were analysed using descriptive statistics and Chi-square/Fisher's exact test for comparison of proportions.
Results
One hundred and fifty eight episodes of asthma were studied in 140 patients, 65 males and 75 females with a median age of 40 [range, 17 to 87 years]. The derivation of the study sample is shown in Figure 1 . Seven patients presented twice, two patients presented three and four times, and one patient presented on seven occasions during the study period. The overall rate of CXR ordering was 68% [mild 54%, moderate 66%, severe 84%] ( Table 1 ). The rate of CXR ordering was significantly higher for the severe group [p=0.0038, omnibus Chi-square].
Of the 107 CXR performed, 11 [10%] showed abnormal findings. However, three of these (an abscess) were in the same patient. If these are treated as one positive and two 'unchanged/normal' (as defined in Methods), the rate of relevant abnormality was 8% [9/107; mild 0%, moderate 9%, severe 14%] ( Table 2 ). The severe category had a significantly higher rate of abnormal CXR findings [p=0.038, omnibus Chi-square].
Of the nine CXRs with new abnormalities, the findings were consolidation [5] , pneumomediastinum [1] , moderate pleural effusion [1] , oval density [1] and 
Discussion
This study found a high utilisation of chest X-rays for ED asthma patients [68%] . This was at odds with the NAG recommendations, particularly in the mild and moderate groups. Only one other study has specifically studied CXR rates in an ED asthma population, albeit in children, reporting a CXR rate of 25%. 4 Although our study was not designed to explore reasons for CXR ordering, possible explanations include habit, a perception that the admitting team would require an X-ray or lack of understanding of the pathophysiology of asthma.
We also showed that 8% of CXR taken displayed a clinically significant abnormality, with the vast majority occurring in the severe group [6 out of 9]. This was higher than other studies of ED asthma populations that had reported abnormality rates of 1% 3 and 2.2%. 2 This may be due to the relatively high proportion of severe asthma exacerbations included in our study as evidenced by the 32% severe classification and 42% admission rate.
In contrast, studies of asthma patients requiring hospital admission have reported abnormality rates on CXR of 9-34%. 4, 5 Our study found an abnormal rate of 13% in this sub-group at the lower end of the reported range. The wide variance probably lies in the definition of 'abnormal'. Petheram's study 4 defined relevant abnormalities as those affecting management (similar to the current study), while White et al 5 had a much more liberal definition of abnormality. Both of these studies concluded that a CXR was warranted in asthmatic patients requiring hospital admission. Our finding of a 14% CXR abnormality rate in exacerbations classified as severe suggests that this group may benefit from CXR, particularly if they fail to improve. The low rates of findings in the mild and moderate groups suggest that routine CXR is not justified. This concurs with the findings of Zieverink 2 and Findley. 3 It was possible that indicators of infection such as temperature and white cell count either influenced the decision to perform a CXR or increased the likelihood of CXR abnormality. We attempted to collect this data but it was not available often enough to perform meaningful analyses. If they were associated with abnormality, particularly with consolidation, they might be useful to assist in deciding which patients would benefit from CXR. This is worthy of further study.
This study has some limitations that should be considered when interpreting the results. There are the standard limitations of retrospective studies, in particular the problems of missing data and data extraction. We attempted to minimise the latter by an explicit data collection process. A significant number of records were unavailable for review (at another campus, in use by an inpatient service, lost, etc.), which may have introduced bias. Patients were identified by ED discharge diagnosis of 'asthma' from an ED database. Eligible asthma patients miscoded or given an alternative coding might have been missed. The study was conducted at a single site so generalisability to other centres cannot be assumed. We also did not attempt to explore the impact of CXR findings on patient management. Classification of asthma was conducted retrospectively by EE.
Conclusion
The rate of CXR ordering in acute asthma was high with a low yield of relevant positive findings in the mild and moderate severity groups. This was at odds with NAG recommendation. Our results suggest that routine CXR may be warranted in patients with severe asthma but should be guided by clinical examination in other severity classes.
